Chancellor Donald, MD, Medical Director of Cancer Management and Oncology services at University Medical Center, has been elected to the American Society of Hematology (ASH) Executive Committee as a councilor. His term begins after the ASH Annual Meeting in December 2024.

A member of ASH since 2008, Dr. Donald has shown unwavering commitment to advancing health equity and advocating for patients with hematologic disorders, particularly those facing care disparities. He has previously chaired ASH’s Committee on Practice and served on its Health Equity Task Force.

Congratulations, Dr. Donald!

xxxxxxxxTODAY @ Noon

TULANE INNOVATION INSTITUTE'S OPEN SEASON

TODAY - 5:30 - 8:30 pm

OAK & ALE

8118 OAK ST.

Join us as we hunt for the next big idea at Tulane! This event is open to everyone in the community who wants to learn more about the entrepreneurship and innovation happening at Tulane University. Free to attend and refreshments will be served.

RSVP

Bootstrapping and Grant Writing

WEDNESDAY, NOVEMBER 20

11:00 AM - NOON

FREE WEBINAR

Uncover the art of self-funding your entrepreneurial dreams. Learn the ins and outs of leveraging personal resources and mastering the grant application game to secure early-stage funding without the pressure of investors. 

REGISTER

Tulane Libraries Workshop

REU Ready? Applying for Summer Internships in STEM

Wednesday, November 20 - 5:00 PM

In Person @ Howard Tilton Memorial Library - Room 602 OR Via ZOOM

Ready to take your research skills to the next level? Plan now to apply for a summer STEM internship! This workshop will help you learn how to find, prioritize, and apply to research internships. Snacks will be provided for those who attend in person.

RSVP

NSF 25-508: Designing Materials to Revolutionize and Engineer our Future (DMREF)

SUBMISSION WINDOW - JAN 21 - FEB 4, 2025 - 5 PM

AWARD AMOUNT: $1,500,000 – $2,000,000 OVER FOUR YEARS



If you are planning a proposal in response to this opportunity, please notify Sponsored Projects Administration at dlovrov@tulane.edu no later than Thursday, November 21, 2024.

DMREF seeks to foster the design, discovery, and development of materials to accelerate their path to deployment by harnessing the power of data and computational tools in concert with experiment and theory. DMREF emphasizes a deep integration of experiments, computation, and theory; the use of accessible digital data across the materials development continuum; and strengthening connections among theorists, computational scientists, data scientists, mathematicians, statisticians, and experimentalists as well as those from academia, industry, and government. 

MORE INFORMATION

General Medical Faculty Meeting featuring an Address by Michael Fitts, JD,

President of Tulane University

Tuesday, November 26 - 5:00 PM

Hutchinson Auditorium

All School of Medicine faculty are encouraged to attend. Light refreshments will be provided at

4:30 p.m. 

NIH Loan Repayment Programs (LRP) Award

APPLICATION DEADLINE - NOVEMBER 21

AMOUNT: $100,000 IN REPAYMENT OF QUALIFIED EDUCATIONAL LOAN DEBT OVER A TWO-YEAR LRP AWARD PERIOD

Explore the LRP website and watch the overview video to learn more.

Summer 2025 Fellowships for Graduate Students at Sandia National Laboratories

APPLICATION DEADLINE -

DECEMBER 1, MIDNIGHT EST

Universities Research Association (URA) is seeking applications for paid Summer 2025 Fellowships for graduate students at Sandia National Laboratories. Detailed information about the program and the application process is available HERE.

URA anticipates making up to ten appointments within Sandia’s participating Research Foundations, including Bioscience; Computing and Information Science; Earth Science; Engineering Science; Material Science; Nanodevices and Microsystems; and Radiation, Electrical, and High Energy Density Science. Applicants must be full-time master’s or doctoral graduate students and US Citizens. 

Call for Proposals:  FY25 Office of Research Bridge Fund Support

APPLICATION DEADLINE: DECEMBER 1, 2024

Purpose

To sustain competitively funded research projects that have temporarily lost extramural support, the OoR Bridge Fund provides one‐time support to eligible Principal Investigators to assist with re‐establishing external funding.

A primary objective of the support is to keep experienced research teams together; thus, priority will be given to retain project staffing temporarily. Also, special consideration will be given to multi‐investigator, convergent, and center‐type projects.

Eligibility

Bridge Fund support is intended for those Principal Investigators who have experienced a substantial reduction from extramural sources, and who can reasonably anticipate regaining competitive support in the upcoming year.

MORE INFORMATION

ORAU Powe Junior Faculty Enhancement Grant Program

PRE-PROPOSAL DEADLINE: MONDAY, DECEMBER 2 - 4:00 PM CST

FULL APPLICATION DEADLINE: JANUARY 8, 2025

AWARD AMOUNT: $5,000 for one year (June 1, 2025 - May 31, 2026)

The applicant’s institution is required to match the award with at least an additional $5,000.

The Ralph E. Powe Junior Faculty Enhancement Awards Program provides seed money for research by junior faculty at ORAU member institutions. These competitive research awards often result in additional funding from other sources. Eligibility for the Powe Awards is open to full-time assistant professors within two years of their tenure track appointment at the time of application (January 1, 2023, to January 7, 2025).

Only two nominations are allowed per institution. Qualifying individuals must send a pre-proposal with CV as one pdf to dlovrov@tulane.edu no later than 4:00 p.m. on Monday, December 2, 2024. Please use this form when preparing your pre-proposal.

MORE INFORMATION

Action for Women's Health - A Global Open Call

APPLICATION REGISTRATION DEADLINE: DECEMBER 3, 4 PM CST

AWARD AMOUNT: $1 million - $5 million USD

Pivotal, a Melinda French Gates organization, launched Action for Women’s Health, a $250 million global open call that will fund organizations around the world that are improving women’s mental and physical health. Eligible organizations should center equity in their approach and be poised to scale their work to strengthen the health of more women. 



MORE INFORMATION

Gilead’s Research Scholars Program in Oncology Solid Tumors

APPLICATION DEADLINE: DECEMBER 6, 2024, at 11:59 PM PST

AWARD AMOUNT: UP TO $180,000

Apply here: Research Scholars Program Solid Tumors Portal 

Gilead’s Research Scholars Program selects junior faculty researchers pursuing an academic career at an institution at the time of application. The Program supports any basic and clinical research limited to breast, bladder, upper gastrointestinal, or lung cancer that addresses an unmet medical need in the field of Oncology Solid Tumors.

Ladies Leukemia League Call for Applications

The Ladies Leukemia League (LLL) - an organization dedicated to raising funds for leukemia and lymphoma research in the Gulf South region - is presently seeking applications for their 2025-2026 grant program.   

GRANT AMOUNT - $35,000

APPLICATION DEADLINE – December 13, 2024

Instructions for preparing your research grant application and other submission documents are available on the Ladies Leukemia League website at Ladies Leukemia League, Inc. of the Gulf South Region - Research Grants

Please note, if your project has been previously funded by another organization or institution, it is not eligible to be funded by the Ladies Leukemia League.

Request for Applications - Predoctoral Clinical/Translational Research Program (T32 Program)

APPLICATION DEADLINE - DECEMBER 16, 2024 - 5:00 PM CST

This one- or two-year fellowship offers:



• NRSA stipend (currently $28,224) for full-time multidisciplinary mentored research training

• $1,500 travel support for ACTS national meeting

• $3,000 childcare reimbursement

• Up to $16,000 tuition support towards Master’s degree/certificate/coursework

• Training-related expenses available to support health insurance & research related costs

MORE INFORMATION

The mission of the Center for Clinical and Translational Science (CCTS) is to address disparities and/or diseases disproportionally represented in the Deep South. Full-time doctoral students at CCTS partner institutions seeking an MD, PhD, DDS, DMD, DVM, and dual-degrees and who will have completed the first two years of their doctoral degree by July 2025 are invited to apply. Candidates must be U.S. citizens or have permanent residency status and must be able to demonstrate a commitment to full-time research training.

Call for Independent Medical Education Grant Applications

Oncology – Urothelial Carcinoma (UC) 

APPLICATION DEADLINE - DECEMBER 24, 2024

The purpose of this CGA is to encourage Organizations with ex - US experience to submit grant applications for independent either accredited or non-accredited activities designed to enhance understanding of the management of urothelial carcinoma (UC). 

MORE INFORMATION

CCTS Partner Network: Postdoctoral Dissemination and Implementation Research Program (T Award)

APPLICATION MATERIALS ACCEPTED ON A ROLLING BASIS WITH A PRIORITY DEADLINE OF MARCH 15, 2024 

This two-year fellowship offers:



• NRSA annual stipend based on years from terminal degree (currently ranging from $56,404 – $68,604) for full-time multidisciplinary mentored research training
• $1,500 travel support for ACTS national meeting
• Tuition support towards degree/certificate/coursework
• Training-related expenses available to support health insurance, childcare & research related costs

MORE INFORMATION

This mentored research training program is currently accepting applications from post-doctoral students in health-related profession programs. Post-doctoral students at all CCTS partner institutions holding an MD, PhD, PharmD, DDS, DMD, DVM, and dual-degrees are invited to apply. Candidates must be U.S. citizens or have permanent residency status and must be able to demonstrate a commitment to full-time research training.

The Fall 2024 NSF Virtual Grants Conference is open for registration!

The U.S. National Science Foundation will host the semi-annual event from December 9 – 12, 2024. This is an excellent opportunity to gain insights into NSF’s current issues, policies and procedures, and specific funding opportunities.

There is no cost to register and attend the Grants Conference.

REGISTER

Startup Sprint Registration is LIVE!

OPEN TO ANYONE

JANUARY 31 - FEBRUARY 2, 2025

Tulane University Lavin-Bernick Center

Imagine launching your own business in just one weekend! The Tulane University Innovation Institute invites the community to join its inaugural Startup Sprint. This three-day event equips aspiring entrepreneurs with the tools and guidance to transform a business idea into reality. Participants will enjoy networking and a collaborative environment, where they can brainstorm, prototype, and refine their ideas as a team. At the conclusion of the event, a cash prize will be awarded to the top pitch. 

Efficacy and Toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data. Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Moradi Tuchayi A, Lawhn-Heath C, Wang T, Carducci MA, Pomper MG, Paller CJ, Czernin J, Solnes LB, Hope TA, Sartor O, Calais J, Gafita A.

J Nucl Med. 2024 Nov 1;65(11):1740-1744. doi: 10.2967/jnumed.124.267816.

PMID: 39327018 Clinical Trial.

Microwave ablation: a technical and clinical comparison to other thermal ablation modalities to treat benign and malignant thyroid nodules. Luo X, Kandil E.

Gland Surg. 2024 Oct 31;13(10):1805-1813. doi: 10.21037/gs-24-221. Epub 2024 Oct 26. PMID: 39544972

Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers. Xu T, Dillon JS, Maluccio MA, Quelle DE, Nash SH, Cho H, Limbach KE, Skill NJ, Bren-Mattison Y, O'Rorke MA.

J Cancer Res Clin Oncol. 2024 Nov 2;150(11):485. doi: 10.1007/s00432-024-06020-w.

PMID: 39488644

Treatment outcomes in patients with papillary thyroid cancer undergoing radiofrequency ablation of metastatic lymph nodes. LaForteza A, Persons E, Hussein M, Luo X, Issa PP, Jishu J, Shama M, Toraih E, Kandil E. Gland Surg. 2024 Oct 31;13(10):1752-1758. doi: 10.21037/gs-24-285. Epub 2024 Oct 26. PMID: 39544984

Personality Feedback With Tailored Self-Care Recommendations Improves Self-Efficacy for Cancer Management: A Randomized Controlled Trial. Perry LM, Mossman B, Garcia SF, Kircher SM, Dunn A, Alonzi S, Easwar S, Hoerger M. Psychooncology. 2024 Nov;33(11):e70023. doi: 10.1002/pon.70023. PMID: 39547948 Clinical Trial.

Impact of Psychological Stressors on Natural Killer Cell Function: A Comprehensive Analysis based on Stressor Type, Duration, Intensity, and Species. Katz AR, Huntwork MP, Kolls JK, Hewes JL, Ellsworth CR, Clark RDE, Carlson JC. Physiol Behav. 2024 Nov 13:114734. doi: 10.1016/j.physbeh.2024.114734. Online ahead of print. PMID: 39547436

Please visit Tulane Cancer Center on Facebook, Instagram and LinkedIn and follow us for all the latest news in cancer research, education and patient care.

You can access our profile pages by clicking on the icons below.

Tulane Cancer Center now has an institutional subscription to The Cancer Letter, an independent weekly newsletter that is the leading source of information on:

• National Cancer Institute
• cancer research funding
• cancer legislation and policy
• the pharmaceutical industry

Our institutional subscription allows anyone with a Tulane IP address to be automatically logged in when visiting www.cancerletter.com. For more information, please click here.

Acknowledging Tulane Cancer Center Support in Publications

We suggest using the following wording when acknowledging Tulane Cancer Center support: "This work was supported by the Tulane Cancer Center, part of Tulane School of Medicine, and a consortium partner of the Louisiana Cancer Research Center."

One of the responsibilities of membership in the Tulane Cancer Center is acknowledgement of Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in presentations and publications

Tulane Cancer Center Branded Assets

Please use the following for your external presentations, external-facing meetings and emails:

1. A Tulane Cancer Center-branded PowerPoint Slide Master
2. A Tulane Cancer Center-branded Scientific Poster Template (sized at 4 feet x 3 feet)
3. Tulane Cancer Center-branded Zoom Backgrounds
4. Tulane Cancer Center’s updated logo
5. Tulane Cancer Center-branded Email Signature Blocks

All Tulane Cancer Center Members should have received these files via a recent listserv email (Subject: Tulane Cancer Center Branded Assets). If you did not receive the email but would like to begin using these templates, please contact Melanie Cross at mcross@tulane.edu. 

Thank you for your assistance in helping us to expand our visibility while showcasing the depth and breadth of our outstanding basic, translational and population science research and clinical care.  

Next Generation Sequence Analysis Core

The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.

More Information 

Cell Analysis Core

The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.

More Information

Tulane Cancer Center & LCRC Membership

Any Tulane University faculty member whose research relates to or could potentially relate to cancer – directly or indirectly – should become a member of the Tulane Cancer Center (TCC). As a member, you have access to TCC's funding opportunities, research collaboration events, and shared resources. Please click here for our membership guidelines and our online application form.

Cancer-focused faculty are also encouraged to become members of the Louisiana Cancer Research Center, a partnership between the State's foremost cancer research institutions - Tulane University School of Medicine, LSU Health Sciences Center New Orleans, Xavier University of Louisiana and Ochsner Health. Membership in the LCRC provides access to additional funding opportunities exclusively offered to LCRC members. Please click here for the LCRC's membership guidelines and online application form.

Trainee Membership in the Tulane Cancer Center

Tulane graduate students, medical students, postdocs, medical school-affiliated residents or fellows, and some undergraduates who are engaged in cancer-focused research can now apply to become Trainee Members of the Tulane Cancer Center.

Trainee Member applicants must be sponsored by a current Tulane Cancer Center Member and, once their membership is approved, will benefit through association with Tulane Cancer Center Research Programs and Disease-Oriented Teams, as well as access to shared resources for cancer-focused projects and invitations to scientific retreats, seminars and special events.

Please share this opportunity with your lab teams and other trainees/mentees.

To access the Trainee Membership Sponsor Nomination Form as well as the online membership application, please click here.

Subscribe to Nexus

If you know someone who is interested in subscribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.

Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.